If stocks were drums then there would be no stock that I have been pounding louder than Intuitive Surgical (NASDAQ: ISRG) for the last decade!

The stock has been moving upward every day for over a week gaining more than 50% in that time. It is up about 11% to $152.00 in mid day trading.

It was only two days ago that I posted Chasing Value: Intuitive Surgical's right price outlining why the stock was a value, but determining the exact value was not possible. If there was anyone that heeded my call then, they must be smiling today.

It is not possible to follow all stocks or companies with equal intensity, focus, or depth of knowledge. One that I have followed for over ten years is Intuitive Surgical, Inc. (NASDAQ: ISRG).

I originally bought in at the very bottom, about $7.70 and last year sold about 20% of our position for $192. The stock had reached an all time high about 18 months ago just shy of $360, so my timing was far from ideal, but I was influenced by other factors. In this case a real estate transaction.

Over the past six months I have been buying more shares and have more than doubled our position. I believe that ISRG remains a growth stock, but for quite some time it has been value priced. However, I cannot tell you what exactly is the right price -- that is a big question.

Alcoa Inc. (NYSE: AA) started off the new earnings season with disappointing results that helped to stifle the recent rally. Was that enough of a sign of what's to come? No, probably not. But the earnings reports start to fly in earnest this week, which should provide a more detailed picture of the state of things.

Analysts surveyed by Thomson Reuters anticipate that some of the biggest names will prove to be holding their own. Google Inc. (NASDAQ: GOOG) is expected to post a profit of $4.91 per share, marginally higher than a year ago, and Johnson & Johnson's (NYSE: JNJ) expected $1.22 per share profit is slightly lower year over year. Even Mattel Inc.'s (NYSE: MAT) estimated loss of $0.13 per share is the same as in the year-ago period.

Given the current state of the economy all would agree it's going to be a long road home. The market is up today on a few bits of news following what has been a dreadful last ten days. Maybe it's the merger and acquisition activity, maybe it's the news that Citigroup Inc. (NYSE: C) "let slip" that they earned a profit the first two months of the year. Perhaps the market was just due for a bounce before another slide?

Every day we read various rationales for why the market may be undervalued, or as some believe, still has a long way to drop. We look at stocks of strong companies with historically low price-to-earnings ratios and think now is the time to get in. However, someone will be quick to point out that forward earnings are perhaps going to be less than projected.

If there is anything that makes me think we could be close to a market bottom, it is all the people that have gone off the deep end thinking the world may be coming to an end.

For the time being highly leveraged debt obligations seem to have come to an end. Large independent investment banks may have come to an end for now. The idea of a balanced budget may have come to an end a long time ago. However, the world is not coming to an end.

If anybody out there thinks that the times we live in come close to the Dark Ages, the American Revolution, the Civil War, World Wars I or II, or the Great Depression, then they are wimps who know nothing about history or true misery.

The 2009 clock is ticking loudly. The year has started off with a lot of continued turbulence. We have a new president, Barack Obama, who will boldly lead us where no man has gone before -- two trillion further in debt, most likely.

Not that this is his doing, but it is his chosen calling, and right now he is calling out to the Senate minority to compromise, and get yet another federal stimulus package off the shelf and out the door.

Over the past week I have heard rumors that Johnson and Johnson (NYSE: JNJ) might acquire Intuitive Surgical Inc. (NASDAQ: ISRG) and this may have caused some of the recent upward movement in ISRG stock. So I am watchful, but I see no facts at all other than the stocks rise on lighter than average trading volume.

It closed yesterday at $110.68. This is 27% above its 52-week low of $87.14 set in the last two weeks. Perhaps the rumors are wishful thinking on the part of some, and a few whispers somewhere in the murkiest alleyways of Wall Street created a story in some editor or promoters mind.

Anybody have capital gains to show this year? I didn't think so. Not unless you were shorting the market, and in particular financials. I got clobbered with everyone else. There were not many places to hide. Picking winners was like guessing where each piece of debris would land after the tornado moved through town.

The average crystal ball is looking quite foggy about now, nevertheless I have rummaged throughout the stock market to select nine stocks that I think offer more reward than risk. The market is priced for the worst in so many cases that I think the list could have included 50 companies without too much trouble.

In 2007 and 2008 I owned some but not all of the picks for the year. This year I own all of the stocks and they were all acquired in the latter part of the fourth quarter for a new portfolio.

There is a lot of money sitting on the sidelines waiting for the right time to get back into the stock market. Maybe that time will be after the Dow Jones Industrial Average tests 7000, or even 6000. Maybe it will be after quarterly reports start turning positive. I'm sure many people will not do anything until the housing market turns around. Then there are those that have sworn off the stock market or at least individual stocks entirely.

These and a multitude of other issues may be keeping you from investing for now and no one could blame you, but if it is your intention to get back in when the coast is clear then you should be making some preparations by putting together your watch list.

Here are some of the stocks on my watch list. I usually have about 20 stocks that I am interested in. Some of them I own already and I am interested in acquiring more. Some have appeared in my Chasing Value column, and some or all might appear there again.

Annaly Capital Management (NYSE: NLY) is one of the stocks mentioned in Fortune Magazines "Ten Promising Stocks for 2009" and is currently paying almost a 15% yield at Fridays closing price of $14.92. The company borrows money at short term rates and only invests in long-term Federally backed mortgages. They have avoided subprime loans and derivatives entirely.

Boardwalk Partners (NYSE: BWP) is expanding and was highlighted today as another high yield value stock Chasing Value: High yield thru Boardwalk's pipes that you can acquire for less than the price the general partners paid in October.

Burlington Northern Santa Fe (NYSE: BNI) can claim Berkshire Hathaway (NYSE: BRK.A) as it's largest shareholder and you can buy shares for less than 'my pal Warren' did.

Intuitive Surgical (NASDAQ: ISRG) is one of my top holdings and favorite companies. I have owned it for years and only selling some shares at $192. I recently started building a new position in a new portfolio in the past few months and I am interested in buying more. It closed at 134.38 on Friday.

This post is part of a series featuring bargain stocks that are worth a look now. See more Cheap Stocks.

Sunnyvale, California, is home to such well-known tech companies as Advanced Micro Devices (NYSE: AMD) and Yahoo! (NASDAQ: YHOO), so it would be easy to dismiss Intuitive Surgical (NASDAQ: ISRG) as a small fish in a big pond. However, the fundamental prospects for this surgical-technology firm prove that ISRG is a heavyweight in its own right.

Intuitive Surgical is best known for its da Vinci surgical systems, which would no doubt impress Leonardo himself. The high-tech platforms allow surgeons to operate through small, minimally invasive ports while maintaining all the benefits of an open-surgery format.

Lately, ISRG has come under pressure as analysts warn of a slowdown in spending by hospitals. A good deal of this anxiety has already been priced into the stock, despite reassurances from CFO Marshall Mohr. On the company's third-quarter conference call, he asserted that a reduction in hospitals' capital expenditures isn't yet on the radar. "At the present time, we don't have any indicators that tell us that that's the case or that anything has changed," said Mohr, adding, "But we're early into this."

Yesterday, in response to Chasing Value: ISRG is falling and I'm buying I received the following comment from Beltway Greg, "You're a brave dude. Why? I've watched this stock for awhile and I worry about possible entry by other folks into the market."

Brave perhaps, even foolish on occasion, but I still think this is the time to be selectively buying equities.

To those that might be concerned about competition for Intuitive Surgical Inc (NASDAQ: ISRG) you will be interested in the following:

• NOTICE TEXT: Department of the Army U.S. Army Medical Command MEDCOM, North Atlantic Regional Contracting Office Subject: Contract prosthetic feet and leg coverings This is a notice of the Governments intent to solicit, negotiate and award a sole source contract (Note 22) contract to Intuitive surgical for Implants based on urgency. This is not a set-aside for small business. This notice is an urgent requirement for Walter Reed Army Medical Center, 6900 Georgia Avenue NW, Washington, DC 20307, contract number W91YTZ-09-P-0147. Parties interested in future announcements shall provide detailed information of their capabilities and certifications to clearly meet the requirements stated above.

It is possible that someday ISRG will have some competition, but there does not seem to be anything on the horizon for now. Furthermore, as the user base expands the barrier to entry increases and the cost of changing systems becomes more challenging.

The most likely scenario for competition would be if another manufacturer were to create a similar system for procedures not yet addressed by ISRG's Di Vinci robotic surgical units. Some of the potential competitors, like Johnson and Johnson (NYSE: JNJ) or Medronic (NYSE: MDT), are actually corporate partners helping to distribute the units world wide. What is most likely from my point of view is that other manufacturers will find a way to partner with ISRG to develop complimentary hardware to expand the capability of the system for more procedures to get to market faster.

Sheldon Liber is the CEO of a small private investment company and the principal for design and research at an architecture & planning firm. He writes the columns Chasing Value and Serious Money.

One of my top holdings, Intuitive Surgical Inc (NASDAQ: ISRG) and favorite stocks is taking a beating this morning and has been along with almost everything else. One of our readers who has been following this story line sent me an email asking what my current thoughts on the subject are. Andrew:

"I'm just curious if you hung on to your ISRG or if you bailed on it... I've been following it since this article, and man, its really heading down to the boiler room... Doctors seeem to be making cuts all over the place, and it looks like ISRG is being taken for a ride... I'm looking at getting in, but maybe if it hits 112 to even as low as sub 100... But I'm curious how you've taken to it?"

As the old saying goes in regards to the stock market, beware trying to catch a falling knife. Regardless, I have been a buyer of late. But first questions first. We did sell 20% of our position for a large gain just under $200 per share, having originally bought in at $7.70. We did not bail out but we did take our original money off the table, and then some.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Advanced Micro Devices Inc. (NYSE: AMD) narrowed its Q3 net loss on rising revenues.
• AMR Corp. (NYSE: AMR) posted a deeper-than-estimated Q3 loss but ordered 42 new planes.
• Citigroup Inc. (NYSE: C) reported its fourth straight quarterly loss on another write-down.
• Coca-Cola Co. (NYSE: KO) posted better-than-expected Q3 results on growth overseas.
• CSX Corp. (NYSE: CSX) reported strong Q3 results on lower fuel prices and cost controls.
• eBay Inc. (NASDAQ: EBAY) topped Q3 expectations but lowered its full-year guidance.
• Gilead Sciences (NASDAQ: GILD) beat expectations, sending shares higher.
• Google Inc. (NASDAQ: GOOG) better-than-expected Q3 results sent shares higher.
• Harley-Davidson Inc. (NYSE: HOG) international growth couldn't overcome disappointing results.
• Hershey Co. (NYSE: HSY) results in Q3 were in line with analysts' expectations.
• IBM (NYSE: IBM) posted strong Q3 results and offered an optimistic outlook.
• Intel Corp. (NASDAQ: INTC) posted strong Q3 results but warned of lower demand in Q4.
• Intuitive Surgical Inc. (NASDAQ: ISRG) strong results easily topped expectations, but shares fell.
• Johnson & Johnson (NYSE: JNJ) posted strong Q3 results and raised its full-year guidance.

The first time I bought Intuitive Surgical Inc (NASDAQ: ISRG) I paid around $7 per share and that is about the lowest point since it went public. Those shares have been sitting in our portfolio as our largest position and our best investment for quite some time.

ISRG makes computer assisted robotic surgical equipment to assist doctors in a growing range of less invasive procedures.

The stock closed yesterday at $214.80. I have been tempted to buy more shares many times over the last few years and regular readers know how much I like this stock: Intuitive Surgical jumps over 32% - where's the ceiling?

Until today I hesitated to buy more because the stock was jumping so fast that I always thought it was slightly ahead of the value. Each time it just went up more.

After the market closed yesterday ISRG reported an increase in revenue and earnings.

• Revenues for the quarter grew 50% over the same period last year. The company's third quarter 2008 net income was $57.6 million, up 41% from $40.9 million reported for the third quarter of 2007. Earnings per share increased to $1.44 from $1.04 in the prior-year comparable quarter. Eleven analysts polled by First Call/Thomson Financial expected the company to earn $1.27 per share for the quarter.

Even though the company beat earnings expectations by $0.17 (13.38%) a share the stock dropped almost 16% a share, since yesterday. Until today I watched the stock go from $7.00, to as high as $359.59, its all-time high and stayed on the sidelines except to buy a little for my kids shortly after our company got in.

Today, with the share price 50% off its high; with investors afraid of their own shadows; with world financial markets in turmoil; I bought more at $180 per share. That is 10 times what my kids shares cost and almost 26 times what I first paid.

This one is a keeper and one of the few stocks besides Berkshire Hathaway (NYSE: BRK.A) that I have ever recommended that does not pay a dividend. Even Warren Buffett has been buying and recently posted a bullish story in the NY Times. The following is the five-year chart for ISRG.

The earnings crunch begins in earnest this coming week, with companies from Johnson & Johnson (NYSE: JNJ) and PepsiCo Inc. (NYSE: PEP) to Southwest Airlines Co. (NYSE: LUV) and Harley-Davidson Inc. (NYSE: HOG) scheduled to report results for the quarter just ended. But with the ongoing turmoil in the markets, much attention is on the tech and financial sectors. This week will provide plenty to mull over on both counts.

Wall Street expectations for tech stocks are fairly optimistic. Analysts surveyed by Thomson Financial are looking for chip maker Altera Corp. (NASDAQ: ALTR) and software/service company iGate Corp. (NASDAQ: IGTE) to be the sector's biggest earnings gainers of the week. Altera is expected to report earnings of 30 cents per share (up 33.3% from a year ago) on revenue of $355.1 million. Altera had previously forecast flat sales for the quarter, and shares fell to a 52-week low last week. iGate is expected to report earnings of 14 cents per share (up 42.9%) on revenue of $55.6 million. India-based iGate recently spun off its Mastech consulting services. Shares are down 45.0% in the past three months, and also reached a new 52-week low last week.

San Jose-based Novellus Systems Inc. (NASDAQ: NVLS), on the other hand, is expected to report that net income tumbled 90.4% from a year ago to 4 cents per share, on revenue of $245.6 million. Novellus fell to a 52-week low early last week, and shares are down 44.5% year to date.